EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma

Xu Feng iD, Qianlan Yao, Yuyin Xu, Jing Zhang, Liqin Jia, Qian Wang, Xu Cai, Ye Xu iD, Fangqi Liu, Dan Huang, Weiqi Sheng, Qianming Bai und 2 weitere

International Journal of Cancer · 15.11.2024 · 155 (10) · 1780-1791

DOI: 10.1002/ijc.35085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 07.08.2024. Verfasst von Xu Feng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, MutL Protein Homolog 1, DNA Methylation, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Group Project of Shanghai Municipal Health Commission, Innovation Program of STCSM (Shanghai Science and Technology Committee), Shanghai Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate different Lynch syndrome (LS) screening approaches and establish an efficient and sensitive strategy are critical for clinical practice. In total, 583 patients with colorectal carcinoma (CRC) at Fudan University Shanghai Cancer Center were enrolled. Patient samples were examined by immunohistochemistry (IHC) and next‐generation sequencing (NGS), and MLH1 promoter hypermethylation (MPH) was detected in MLH1‐deficient cases. Germline genetic testing was performed in cases with deleterious variants and large genomic rearrangements (LGRs) of tumor MMR genes were detected in cases with dMMR or MSI‐H cases with no MMR germline variants. Our results showed that triage with IHC and followed by BRAF / MLH1 methylation testing (Strategy 1) identified 93.3% (70/75) of LS cases. IHC followed by germline NGS (Strategy 2) or direct tumor NGS (Strategy 3) both identified 98.7% (74/75) of LS cases. The proportion of LGRs in LS cases was 16.0% (12/75), while 84.0% (63/75) showed SNV/Indel. The average cost per patient was ¥6010.81, ¥6058.48, and ¥8029.98 for Strategy 1, Strategy 2 and Strategy 3, respectively. The average time spent on different strategies was 4.74 days (Strategy 1), 4.89 days (Strategy 2), and 14.50 days (Strategy 3) per patient, respectively. LS and Lynch‐like syndrome (LLS) were associated with an earlier onset age than MPH. In conclusion, we compared different workflows for LS screening and IHC plus germline NGS is recommended for LS screening when taking sensitivity, time, and cost into account. Moreover, multiplex ligation‐dependent probe amplification made up for the shortcoming of NGS and should be incorporated into routine screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisMutL Protein Homolog 1DNA MethylationHigh-Throughput Nucleotide SequencingDNA Mismatch RepairColorectal NeoplasmsHumansFemaleMaleMiddle AgedAgedAdultImmunohistochemistryGenetic TestingEarly Detection of CancerGerm-Line MutationPromoter Regions, GeneticProto-Oncogene Proteins B-rafMicrosatellite Instability

Stichwörter der Autor:innen

Lynch syndromeNGScolorectal carcinomamicrosatellite instability

Substanzen

MutL Protein Homolog 1MLH1 protein, humanProto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Institute of Pathology, Fudan University, Shanghai, China.
  • Department of Colorectal Surgery, Fudan University, Shanghai Cancer Center, Shanghai, China.

ORCID-Profile: Xu Feng, Ye Xu

Förderung

  • Innovation Group Project of Shanghai Municipal Health Commission
  • Innovation Program of STCSM (Shanghai Science and Technology Committee)
  • Shanghai Science and Technology Development Foundation
  • Shanghai Municipal Key Clinical Specialty
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Feng, X., Yao, Q., Xu, Y., Zhang, J., Jia, L., Wang, Q., Cai, X., Xu, Y., Liu, F., Huang, D., Sheng, W., Bai, Q., Zhu, X., & Zhou, X. (2024). Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma. International Journal of Cancer, 155(10), 1780-1791. https://doi.org/10.1002/ijc.35085

Vancouver

Feng X, Yao Q, Xu Y, Zhang J, Jia L, Wang Q, et al. Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma. International Journal of Cancer. 2024;155(10):1780-1791. doi:10.1002/ijc.35085

BibTeX
@article{Feng2024,
  author = {Feng, Xu and Yao, Qianlan and Xu, Yuyin and Zhang, Jing and Jia, Liqin and Wang, Qian and Cai, Xu and Xu, Ye and Liu, Fangqi and Huang, Dan and Sheng, Weiqi and Bai, Qianming and Zhu, Xiaoli and Zhou, Xiaoyan},
  title = {Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {10},
  pages = {1780--1791},
  doi = {10.1002/ijc.35085}
}
Kostenlos starten →